Sort
64,565 grants matching “drug discovery”
RNA Metabolism in Trypanosomes
$751,764Christian Tschudi · Yale University · R01 · FY2020 · AI
Discovery of Selective Inhibitors for the EphA4 Kinase
$751,756Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AG
Frontotemporal Dementia Induced Pluripotent Stem Cell Consortium
$751,616Yadong Huang · J. David Gladstone Institutes · R01 · FY2013 · NS
Nonlipogenic ABCA1 inducers for ADRD
$751,598Gregory R J Thatcher · University Of Arizona · U01 · FY2024 · AG
Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research
$751,587Prem Khovabutr Premsrirut · Mirimus, Inc. · R44 · FY2018 · CA
Targeting the Genus Leishmania with Small Molecules
$751,549Scott Edward Schaus · Boston University (Charles River Campus) · R01 · FY2023 · AI
A Community Zebrafish Resource for Modeling GWAS Biology
$751,471Calum A. Macrae · Brigham And Women'S Hospital · R24 · FY2017 · OD
Chemoprotectants for Head-Neck Therapeutics
$751,436Haiching Ma · Reaction Biology Corporation · R44 · FY2011 · CA
Evolution and inhibition of carbapenemase in beta-lactam resistance
$751,397Yu Chen · University Of South Florida · R01 · FY2021 · AI
Improving vaccine development through high-throughput immunogenicity screening.
$751,389Benjamin Delbert Brooks · Carterra, Inc. · R44 · FY2017 · AI
Simplifying encoding of bioassays to accelerate translational drug discovery
$751,387Barry A Bunin · Collaborative Drug Discovery, Inc. · R44 · FY2015 · TR
Regulatory T Cells in Autoimmune Disease
$751,375David A. Hafler · Brigham And Women'S Hospital · U19 · FY2009 · AI
Repurposing novel selective drugs for treatment and decolonization of vancomycin resistant enterococci
$751,315Mohamed Seleem · Purdue University · R01 · FY2019 · AI
Regulation of Candida albicans Pathogenesis by Protein Kinase and Transcription Factor Networks
$751,293Damian J Krysan · University Of Iowa · R01 · FY2024 · AI
Visant-Predictome: A System for Integration, Mining, Visualization and Analysis
$751,232Charles Delisi · Boston University (Charles River Campus) · R01 · FY2013 · GM
Harnessing Diverse Bioinformatic Approaches To Repurpose Drugs For Alzheimers Disease And Related Dementias
$751,103Mark W Albers · Massachusetts General Hospital · R01 · FY2025 · AG
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
$751,074Afshin Dowlati · Case Western Reserve University · U01 · FY2008 · CA
Identification of metabolic alterations during cortical development in a human cellular model for 22q11.2 deletion syndrome
$750,932Anca Mirabela Pasca · Stanford University · R01 · FY2025 · MH
Discovery and validation of drug resistance mutations
$750,894Eric H. Rubin · Harvard Medical School · U19 · FY2016 · AI
Visant-Predictome: A System for Integration, Mining, Visualization and Analysis
$750,810Charles Delisi · Boston University (Charles River Campus) · R01 · FY2015 · GM
Risk Factors for Ischemic Stroke
$750,808Kathryn M Rexrode · Brigham And Women'S Hospital · R01 · FY2017 · HL
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$750,806Suresh S Ramalingam · Emory University · UG1 · FY2020 · CA
Digital representation of chemical mixtures to aid drug discovery and formulation
$750,747Barry A Bunin · Collaborative Drug Discovery, Inc. · R44 · FY2021 · TR
Pharmacogenomic discovery of therapeutic targets for corrector-refractory cystic fibrosis
$750,672Ron R Kopito · Stanford University · R01 · FY2025 · HL
Integrated, Individualized, Intelligent Prescribing (I3P)
$750,650Joshua C. Denny · Vanderbilt University · U01 · FY2014 · HG